Construction, purification, and characterization of a chimeric TH1 antagonist

BACKGROUND: TH1 immune response antagonism is a desirable approach to mitigate some autoimmune and inflammatory reactions during the course of several diseases where IL-2 and IFN-γ are two central players. Therefore, the neutralization of both cytokines could provide beneficial effects in patients s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bello-Rivero, Iraldo, Torrez-Ruiz, Yeny, Blanco-Garcés, Elizabeth, Pentón-Rol, Giselle, Fernández-Batista, Osmani, Javier-González, Luís, Gerónimo-Perez, Haydee, López-Saura, Pedro
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1481661/
https://www.ncbi.nlm.nih.gov/pubmed/16716222
http://dx.doi.org/10.1186/1472-6750-6-25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1481661/
https://www.ncbi.nlm.nih.gov/pubmed/16716222
http://dx.doi.org/10.1186/1472-6750-6-25

Ejemplares similares